- Home
- APGE vs EXTR Comparison
APGE vs EXTR Comparison
Compare APGE & EXTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APGE | EXTR |
|---|---|---|
| Founded | 2022 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.1B |
| IPO Year | 2023 | 1999 |
Fundamental Metrics
Financial Performance| Metric | APGE | EXTR |
|---|---|---|
| Price | $132.71 | $30.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 5 |
| Target Price | ★ $109.67 | $21.20 |
| AVG Volume (30 Days) | ★ 4.0M | 2.0M |
| Earning Date | 05-12-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 90.91 |
| EPS | N/A | ★ 0.18 |
| Revenue | N/A | ★ $1,140,067,000.00 |
| Revenue This Year | N/A | $13.33 |
| Revenue Next Year | N/A | $7.97 |
| P/E Ratio | ★ N/A | $174.72 |
| Revenue Growth | N/A | ★ 2.05 |
| 52 Week Low | $34.34 | $13.48 |
| 52 Week High | $133.16 | $32.29 |
Technical Indicators
Market Signals| Indicator | APGE | EXTR |
|---|---|---|
| Relative Strength Index (RSI) | 81.42 | 63.81 |
| Support Level | $75.41 | $27.59 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 4.21 | 1.35 |
| MACD | 5.57 | -0.15 |
| Stochastic Oscillator | 99.15 | 71.28 |
Price Performance
Historical ComparisonAbout APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About EXTR Extreme Networks Inc.
Extreme Networks Inc provides AI-powered cloud networking, focused on delivering simple and secure solutions that help businesses address challenges and enable connections among devices, applications, and users. The group designs, develops, and manufactures wired, wireless, and software-defined wide area network (SD-WAN) infrastructure equipment. It has one reportable segment, the development, marketing, and sale of network infrastructure equipment and related software. The Company operates in three geographical areas: Americas, EMEA, and APAC.